Drug intelligence / Profile preview

Regulatory Donor-Derived Dendritic Cell

Development stage
Phase 2
Lead developer
University of Pittsburgh
Modality
Dendritic Cell Vaccines → Immune Effector Cells → Other Cell Types → Cell Therapies
Administration
Intravenous
01

Overview

Regulatory Donor-Derived Dendritic Cells (DCreg) are a type of cellular therapy derived from donor bone marrow cells that are processed to exhibit immunoregulatory properties. These cells are designed to promote transplant tolerance by down-regulating alloimmune responses. DCreg express a tolerogenic gene transcriptional profile, high cell surface programed death ligand-1 (PD-L1):CD86 ratios, high IL-10 production with no IL-12 production, and demonstrate poor ability to stimulate allogeneic T cell proliferation. They are resistant to maturation and to becoming immunogenic after exposure to pro-inflammatory stimuli. In transplantation, DCreg are typically infused into recipients before organ transplantation to help reduce dependency on immunosuppressive drugs and potentially promote operational tolerance.

Other names
donor-derived regulatory dendritic cellDCregtolerogenic dendritic cell (donor-derived)
02

Targets

IL10RA (Interleukin-10 Receptor)PDCD1 (Programmed cell death protein 1 receptor)

Beyond the preview

Go deeper on Regulatory Donor-Derived Dendritic Cell.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Regulatory Donor-Derived Dendritic Cell.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call